跳至主要内容
临床试验/JPRN-jRCT1031210446
JPRN-jRCT1031210446招募中未知

Study on the efficacy and safety of Remimazolam in one lung ventilation. - SEREV study

Hirotsugu Okamoto0 个研究点目标入组 70 人开始时间: 2021年11月24日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Patients aged 20 years and older undergoing lung surgery with one-lung ventilation and general anesthesia with epidural

排除标准

  • If the research subject refuses to cooperate in the research.
  • Contraindications to the use of anesthetics.
  • If the subject has a disease that affects HPV.
  • In the case of a procedure in which one lung ventilation is frequently released intraoperatively, such as surgery for pneumothorax.
  • Patients with longitudinal tumors in the supine position who may require only short periods of one-lung ventilation.
  • If the patient is scheduled to receive intraoperative cardiopulmonary ventilation.
  • Patients with severe chronic lung disease (1 sec rate 50%or less, % lung capacity less than 80%)

研究者

发起方
Hirotsugu Okamoto

相似试验